Guided Therapeutics Inc. (OTCMKTS:GTHP – Get Free Report) traded down 6.7% during trading on Tuesday . The company traded as low as $0.1989 and last traded at $0.23. 27,565 shares traded hands during trading, an increase of 87% from the average session volume of 14,717 shares. The stock had previously closed at $0.2464.
Guided Therapeutics Price Performance
The stock has a market capitalization of $21.27 million, a PE ratio of -4.60 and a beta of 0.57. The stock’s 50 day simple moving average is $0.34 and its two-hundred day simple moving average is $0.31.
About Guided Therapeutics
Guided Therapeutics, Inc is a medical device company focused on the development and commercialization of non‐invasive optical diagnostic platforms for women’s health. Its flagship product, the LuViva® Advanced Cervical Scan, combines hyperspectral and reflectance imaging to support the early detection of cervical epithelial abnormalities. By capturing tissue fluorescence and reflectance signatures in real time, LuViva is designed to augment traditional visual inspection methods and assist clinicians during colposcopic evaluations.
The company secured 510(k) clearance from the U.S.
Featured Stories
Receive News & Ratings for Guided Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guided Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
